Fig. 4From: Effects of switching from sacubitril/valsartan to valsartan alone on plasma levels of natriuretic peptides and myocardial remodeling in heart failure with reduced ejection fractionComparison of LV WS between the baseline and week 24 in the ARB-switch and ARNI-continue groups. (A) ESWS and (B) PSWS. Values are mean ± standard deviation. ARNI angiotensin receptor-neprilysin inhibitor; ARB angiotensin-receptor blockerBack to article page